Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
7
×
sanofi
7
×
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
abbvie
deals
fda
alnylam pharmaceuticals
amgen
astrazeneca
cancer
cancer immunotherapy
gene therapy
gilead sciences
What
bio
roundup
drug
alzheimer’s
deal
latest
medicines
pharma
pharmaceutical
prices
abbvie’s
acquire
acquisitions
agreed
ahead
american
announced
annual
ash
away
billion
biofourmis
blood
borne
bringing
brings
bucks
cancer
cancers
cash
celebrate
ceo
ceos
chance
cholesterol
collabs
companies
company
compound
conference
Language
unset
Current search:
sanofi
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel